Quality is literally at the heart of the Fagron logo and in everything we do. Our quality standards are not only high internally, but also internationally tested: GMP/GDP compliance, full traceability, extensive testing and certifications ensure that our products meet the most stringent requirements. Thanks to quality systems and internal and external audits, we continuously confirm this standard and our customers can always rely on it.

Personalised medicine can only be achieved through customisation, and customisation is only possible with a wide range of products. Fagron offers the widest range on the market — from raw materials and excipients to medical devices, sterile preparations and customised medication — with a single point of contact for all products and services. This combination of depth (specialisations) and breadth (range) enables our customers to find exactly what they need. This facilitates customisation and efficiency, with the right individual solution for each patient.

For us, service is synonymous with partnership. It is more than just delivery; it stands for personal contact, expert advice, expertise, rapid support with logistical questions and knowledge transfer. The aim is for every customer to feel truly supported at every step; we think along with them and take care of everything.

Availability and delivery reliability are crucial in healthcare. Fagron combines a strong stock position, extensive logistics networks and production at multiple locations with efficient processes — ensuring fast delivery. We think flexibly, offering “ordered today, delivered tomorrow” or even overnight delivery in emergencies, which perfectly matches the expectations of the healthcare sector.

Fagron's origins and strategy are deeply rooted in innovation. Since its foundation in Rotterdam in 1990, the focus has always been on developing new, scientifically based solutions for extemporaneous preparations and personalised medication. Fagron not only brings innovative products to market, but also develops new concepts in collaboration with pharmacists, doctors and universities. It is in our DNA and contributes to the future of personalised medicine.